New hope for rare obesity syndromes? weekly injection trial begins
Disease control
Recruiting now
This study is testing how well a weekly weight loss medication called tirzepatide works for one year in young adults (ages 18-26). It aims to compare its effects in people with rare, hard-to-treat obesity from genetic conditions like Prader-Willi Syndrome against those with gener…
Phase: PHASE4 • Sponsor: Grace Kim • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC